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ABSTRACT
Methods: MT microspheres were prepared using emulsion cross-linking method. Polymer-drug compatibility study was done using Fourier transform 
infrared. Physical characteristics were evaluated by particle size,SEM, flow properties etc. In vitro studies for evaluating drug release for MT-loaded 
chitosan microspheres were done by dissolution study.
Results: Particle size of the formulated microspheres was found to be within the range of 110-130 µm. Flow properties of F1-F7 such as angle of 
repose, bulk density, and tapped density were found to be within limits. Drug entrapment efficiency was found to be better for all the formulations 
within the range of 74.82-84.32% w/w. Drug loading capacity was found to be in the range of 56-83.2% w/v. In vitro drug release was found to be in 
the range of 81.32-96.23% w/v.
Conclusion: In spite of all the above results, we conclude that F5 formulation was optimized depending on the data obtained from the drug loading 
capacity and percentage drug release studies. F5 formulation is formulated with drug-polymer ratio 1:2 with 1% of di octyl sodium sulfo succinate 
and 8 ml of glutaraldehyde as a cross-linking agent.
Keywords: Metronidazole, Chitosan microspheres, Scanning electron microscopy, Cross-linking.
INTRODUCTION [1,2]
Microspheres are small spherical particles, with diameters in the 
micrometer range (typically 1-1000 μm). Microspheres are sometimes 
referred to as microparticles. Microspheres can be manufactured from 
various natural and synthetic materials. Glass microspheres, polymer 
microspheres, and ceramic microspheres are commercially available. 
Solid and hollow microspheres vary widely in density and therefore 
are used for different applications. Hollow microspheres are typically 
used as additives to lower the density of a material. Solid microspheres 
have numerous applications depending on what material they are 
constructed of and what size they are. Polyethylene and polystyrene 
microspheres are two most common types of polymer.
Metronidazole (MT) is a synthetic, chemotherapeutic drug, which is 
a derivative of nitroimidazole. MT is one of the most effective drugs 
in the eradication of Helicobacter pylori, which resides mainly in the 
gastric mucosa and is an etiologic factor in the development of gastritis, 
gastric ulcer, and gastric carcinoma [3]. The objective of this study was 
to prepare and evaluate Metronidazole loaded chitosan microspheres 
by emulsion cross-linking technique [4]. The obtained microspheres 
were characterized for size, morphology, drug loading, and entrapment 
efficiency. The particle size was determined by scanning electron 
microscopy (SEM) [5,14]. The in vitro drug release and mathematical 
modeling of MT release were also evaluated.
METHODS
MT was purchased from Max-Med Laboratories, Chennai. Chitosan and 
potassium dihydrogen phosphate were purchased from Chenchems, 
Chennai. Glutaraldehyde, n-hexane, sodium dihydrogen phosphate, and 
sodium hydroxide were purchased from Microfine, Chennai.
Chitosan microspheres containing MT were prepared by emulsion 
cross-linking technique (Table 2). The chitosan solution was prepared 
in 5% aqueous acetic acid, in which the drug was dispersed. The 
resultant mixture was extruded through a syringe (no. 20) into 100 ml 
of liquid paraffin (heavy and light, 1:1 ratio) containing 0.2% w/v of di 
octyl sodium sulfo succinate (DOSS). The stirring was performed using 
a magnetic stirrer with the speed of 1200 rpm. After 2 minutes, 4 ml of 
glutaraldehyde saturated toluene was added into the dispersion. Then, 
after 15 minutes, additional 4 ml of 25% aqueous glutaraldehyde was 
added drop by drop and stirring was continued for additional 3 hr. The 
microspheres thus obtained were filtered and washed several times 
with n-hexane to remove traces of oil. They were then washed thrice 
with ice cold water to remove acetic acid and glutaraldehyde. The 
microspheres were then dried in hot air oven at 50°C overnight and 
stored in desiccators at room temperature.
Process variables
Different formulations were formulated with varying polymer:drug 
ratio (1:1, 1.5:1, 2:1),  di octyl sodium sulfo succinate (DOSS) (0.5%-1%), 
cross-linking agent volume (8 ml, 9 ml, and 10 ml) and keeping a speed 
of rotation of 1200 rpm for all the formulations (Table 1).
Evaluation of microspheres [4]
The shape and surface characteristics of chitosan microspheres was 
assessed by SEM (Fig. 1). The particle diameters of more than 200 
microspheres were measured randomly. The average particle size 
was determined. Drug encapsulation efficiency was quantified using 
a spectrophotometric method. The microspheres drug content was 
determined by ultraviolet (UV) spectrophotometry. Flow property was 
quantified. In vitro drug release studies in simulated gastrointestinal 
fluids (SGFs).
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i10.19903
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Objective: To optimize and evaluate the formulation of metronidazole (MT)-loaded chitosan microspheres and to investigate the efficiency of 
biodegradable polymer in developing sustained release formulation of MT to prolong the action of drug.
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Microsphere morphology [7]
The shape and surface characteristics of chitosan microspheres were 
assessed by SEM, and size distribution of microspheres was determined 
by optical microscopy.
Fourier transform infrared (FTIR) of MT-chitosan microspheres [8,9]
The compatibility of the drug and polymer was evaluated by FTIR 
(Fig. 2 and Table 4).
Particle size distribution of microspheres [7]
The particle diameters of more than 200 microspheres were measured 
randomly. The average particle size was determined.
Drug encapsulation efficiency of MT microspheres [10]
The microspheres containing drug equivalent to 50 mg of MT were 
dissolved in 50 ml of HCl (0.1 N). After complete dissolution of chitosan, 
the amount of drug was quantified using a spectrophotometric method 
at 320.5 nm against the blank.
Drug loading capacity
The microspheres’ drug content was determined by the UV 
spectrophotometry. A weighed amount of drug-loaded microspheres 
was dissolved in 1 ml of chloroform, followed by the addition of 9 ml 
of methanol to precipitate the polymer. The resulting suspension was 
centrifuged and the supernatant liquid was filtered and analyzed in the 




Weight of addeddrug weight of addedpolymer+
Flow properties
Angle of repose
The angle of repose is the constant, three-dimensional angle (relative 
to horizontal base) assumed by a cone-like pile of material formed by 
any of several different methods. When the angle of repose exceeds 50°, 
the flow is rarely acceptable for manufacturing purposes (Table 3) [11].
Apparent bulk density
The bulk density was determined by transferring the accurately 
weighed sample of powder to the graduated cylinder. The initial volume 
and weight were noted. Ratio of weight of the sample was calculated 
using the formula [12]:
Density = Mass/Volume
Tapped density
The tapped density was determined by transferring the powder sample 
to the graduated cylinder. Fixed number of tappings was given(500). 
The tapped density was determined by the following formula.
Density = Mass/Tapped density
Percentage compressibility
Based on the apparent bulk density and the tapped density, the percentage 
compressibility of the bulk drug was determined by the formula [13].
Hausner ratio
It indicates the flow properties of powder and is measured by the ratio 
of tapped density to bulk density [15].
In vitro drug release studies in SGFs [9]
Chitosan microspheres were evaluated for in vitro drug release in 
SGFs [16]. The drug release study of microspheres was performed 
by the Basket method (Model TDT-08L, Electrolab) specified in 
USP 1. Microspheres (equivalent to 50 mg of drug) were weighed 
accurately and filled in gelatin capsule [17,18,19]. Capsule was taken 
Table 1: Formulation table
Ratios
Polymer:Drug 1:1 1.5:1 2:1
Surfactant:DOSS 0.5% w/v 0.75% w/v 1% w/v
Volume of cross-linking 
agent
8 ml 9 ml 10 ml
DOSS: Di octyl sodium sulfo succinate












F1 1:1 0.5% 8
F2 1:1.5 0.5% 8
F3 1:2 0.5% 8
F4 1:2 0.75% 8
F5 1:2 1% 8
F6 1:2 0.5% 9
F7 1:2 0.5% 10
DOSS: Di octyl sodium sulfo succinate
Fig. 2: FTIR Scanning electron microscopy (F5)
Fig. 1: Particle before drug dissolution study (F5)
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in the basket which was immersed in 500 ml of dissolution medium. 
The basket was rotated at 100 rpm at 37°C ± 0.5°C. Perfect sink 
conditions were maintained during the drug dissolution study period. 
The simulation of G1 transit condition was achieved by altering the 
pH of dissolution medium at different time intervals. The pH of the 
dissolution medium was kept 1.2 for 2 hrs using 0.1 N HC1. Then, 
KH2PO4 (1.7 g) and Na2HPO42H2O (2.2 g) were added to the dissolution 
medium, the pH was adjusted to 4.5 with 1.0 M NaOH, and the release 
rate study was continued for additional 2 hrs. After 4 hrs, the pH of the 
dissolution medium was adjusted to 7.4 with 0.1 N NaOH, and release 
studies were extended up to 24 hrs. 5 ml samples were withdrawn 
from the dissolution medium at various time intervals using pipette 
with a treated cellophane membrane. The samples pipetted out were 
suitably diluted with 1.2 pH buffer and the rate of MT release was 
analyzed with the aid of an UV spectrophotometer and absorbance 
was recorded at 320.5 nm [20,21]. The receptor volume was 
maintained constant by replacing with an equivalent amount of buffer. 
The concentrations of MT in the samples were calculated by reference 
to the calibration curve. All dissolution studies were performed in 
triplicate.
Microsphere morphology
The obtained microspheres were found to be spherical in shape using 
SEM [22].
Particle size distribution study
Particle size of the formulated microspheres was found to be within the 
range of 110-130 µm (Fig. 3) [23-26].
RESULTS
For F1 formulation, percentage yield – 75.3% w/w, particle size 
– 50-70 µm, angle of repose – 24o, bulk density – 0.467 g/ml, tapped 
density – 0.613 g/ml, Hausner ratio – 1.215, % compressibility – 
16.900%, drug entrapment efficiency – 75.32% w/v, drug loading 
capacity – 56.12% w/v, and in vitro drug release at the end of 24 hrs 
– 86.49% w/v.
For F2 formulation, percentage yield – 76.67% w/w, particle size – 
70-90 µm, angle of repose – 23°, bulk density – 0.447 g/ml, tapped 
density – 0.684 g/ml, Hausner ratio – 1.250, % compressibility – 
13.200%, drug entrapment efficiency – 80.12% w/v, drug loading 
capacity – 63.87% w/v, and in vitro drug release at the end of 24 hrs 
– 83.41% w/v.
For F3 formulation, percentage yield – 72% w/w, particle size – 
50-70 µm, angle of repose – 23o, bulk density – 0.547 g/ml, tapped 
density – 0.552 g/ml, Hausner ratio – 1.190, % compressibility – 
15.430%, drug entrapment efficiency – 82.50% w/v, drug loading 
capacity – 68.71% w/v, and in vitro drug release at the end of 24 hrs 
– 81.32% w/v.
For F4 formulation, percentage yield – 72.6% w/w, particle size – 
90-110 µm, angle of repose – 24o, bulk density – 0.432 g/ml, tapped 
density – 0.432 g/ml, Hausner ratio – 1.136, % compressibility – 
12.765%, drug entrapment efficiency – 82.59% w/v, drug loading 
capacity – 74.38% w/v, and in vitro drug release at the end of 24 hrs 
– 84.32% w/v.
For F5 formulation, percentage yield – 88.0% w/w, particle size – 
110-130 µm, angle of repose – 21°, bulk density – 0.533 g/ml, tapped 
density – 0.591 g/ml, Hausner ratio – 1.161, % compressibility – 
11.430%, drug entrapment efficiency – 84.32% w/v, drug loading 
capacity – 83.2% w/v, and in vitro drug release at the end of 24 hrs 
– 96.23% w/v. The morphological examination of the MT-loaded 
chitosan microspheres was performed by SEM. The MT-loaded chitosan 
microspheres were spherical in shape and had a smooth surface without 
pores or cavities, which could affect the release of encapsulated drug. 
The presence of polymer debris and accumulation of microspheres 
were observed for few particles that may be caused by the presence of 
liquid paraffin. Overall, all the microspheres were found to be smooth 
and spherical in shape.
Fig. 3: Size range versus frequency
Table 3: Flow properties of microspheres
Formulation code Angle of repose (°) Bulk density (g/ml) Tapped density (g/ml) Hausner ratio Percentage 
compressibility
F1 24 0.467 0.613 1.215 16.900
F2 23 0.447 0.684 1.250 13.200
F3 23 0.547 0.552 1.190 15.430
F4 24 0.432 0.432 1.136 12.765
F5 21 0.533 0.591 1.161 11.430
F6 22 0.432 0.543 1.195 11.999
F7 23.3 0.464 0.439 1.165 15.988
Table 4: FTIR chart of metronidazole-chitosan microspheres
S. No. Wave number Bond Mode
1 2925.92 C-H Stretching
2 3474.77 C=O Stretching
3 3649.46 N-H Stretching
4 2361.05 C≡C Stretching
5 1456.72 C-H Bend in plane
FTIR: Fourier transform infrared
Table 5: Drug entrapment efficiency and drug loading capacity
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Time F1 F2 F3 F4 F5 F6 F7
With buffer pH - 1.2
1 0 0 0 0 0 0 0
2 26.31 29.42 24.42 25.24 22.32 26.42 20.21
With buffer pH - 4.5
4 38.26 35.37 39.28 32.17 42.83 39.28 35.28
6 45.17 49.26 45.92 38.28 59.43 49.25 44.43
8 54.28 63.42 53.48 49.24 63.48 50.23 53.24
12 63.24 71.23 64.97 55.28 79.28 62.29 65.96
With buffer pH - 7.4
18 74.91 78.89 73.28 67.92 86.42 73.42 77.49
20 86.49 83.41 78.14 77.77 91.17 85.49 86.42
24 - - 81.32 84.32 96.23 90.32 91.42
Fig. 4: Flow property
Table 6: In vitro drug release
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For F6 formulation, percentage yield – 86.4% w/w, particle size – 150-
170 µm, angle of repose – 22o, bulk density – 0.432 g/ml, tapped density 
– 0.543 g/ml, Hausner ratio – 1.195, % compressibility – 11.999%, drug 
entrapment efficiency – 76.55% w/v, drug loading capacity – 75.24% 
w/v, and in vitro drug release at the end of 24 hrs – 90.32% w/v.
For F7 formulation, percentage yield – 83.2% w/w, particle size – 
70-90 µm, angle of repose – 23.3o, bulk density – 0.464 g/ml, tapped 
density – 0.439 g/ml, Hausner ratio – 1.165, % compressibility – 
15.988%, drug entrapment efficiency – 74.82% w/v, drug loading 
capacity – 72.43% w/v, and in vitro drug release at the end of 24 hrs 
– 91.42% w/v.
Commonly, the FTIR shows no interaction for all the formulations 
F1-F7.
Hence, in spite of all the data obtained from other formulations, F5 
formulation observed to be the best formulation.
DISCUSSION
The range of percentage yield was found to be from 72.6% to 88%. 
The percentage yield was found to be in the range of 75.3%-88% for 
F1-F7. It was observed that as the drug to the polymer ratio in the 
formulation from F1 to F7 increased, the product yield decreased 
(Table 4). Less percentage yield in some formulations may be due 
to the loss of microspheres during washing and drying. 100% yield 
cannot be achieved in the production of microspheres because of the 
homogenization and change of glass-wares during filtration and drying. 
The microspheres stick to the filter paper while drying. There may be 
loss even on aeration.
Particle size of the formulated microspheres was found to be within the 
range of 110-130 µm. Flow properties of F1-F7 such as angle of repose, 
bulk density, and tapped density were found to be within limits. The 
angle of repose of F5 formulation was found to be 21° (Table 3). The 
bulk density was found to be 0.533 g/ml. The tapped density was found 
to be 0.591 g/ml. The Hausner ratio was found to be 1.161 (Fig. 4). The 
% compressibility was found to be 11.43. Drug entrapment efficiency 
was found to be better for all the formulations (F1-F7) within in the 
range of 74.82-84.32% w/w (Table 5). Drug loading capacity was found 
to be in the range of 56-83.2% w/v (Fig. 5). In vitro drug release was 
found to be in the range of 81.32-96.23% w/v (Fig. 6).
The scanning electron photomicrographs of F5 show that the drug-
loaded microspheres were round and smooth in appearance. Hence, 
after comparing all the results of all formulations, F5 was found to be 
the best formulation, so the SEM studies were done for the same.
The FTIR shows that there is no interaction between the polymer 
and the drug for the formulations such as MT, chitosan, MT-chitosan 
microspheres, blank microspheres, and MT and chitosan raw materials.
The stability study was initiated for the optimized formulation F5 at 
25°C ± 2°C/60% RH and 40°C ± 2°C/75% RH.
CONCLUSION
The percentage yield of the formulation F5 was in the range of 88.0 as and 
when compared to other formulations. The loss of microspheres arises 
in the process of drying and washing. The maximum particle size of the 
optimized formulation was found to be in the range of 110-130 µm. The 
flow property of the formulated microspheres was good for formulation 
F5 as compared to the other formulations. The drug entrapment 
efficiency of the F5 formulation was found to be 82.50% w/v. Hence, the 
drug got well entrapped in the formulation. The drug loading capacity of 
the F5 formulation was found to be 83.2% w/v. The in vitro drug release 
of F5 formulation was found to be 96.23% w/v at the end of 24 hr. The 
SEM shows that the microspheres are round and smooth in appearance. 
Hence, by the results of all the formulations, F5 was found to be the best 
formulation, so the SEM studies were done for the same.
In spite of all the above results, we conclude that F5 formulation was 
optimized depending on the data obtained from the drug loading 
capacity and percentage drug release studies. F5 formulation is 
formulated with drug-polymer ratio 1:2 with 1% of DOSS and 8 ml of 
glutaraldehyde as a cross-linking agent. Hence, biopolymeric carrier 
formulated with chitosan for sustained release delivery of MT was 
found to render acceptable drug loading capacity (83.2% w/v) and the 
percentage drug release rate was found to be 96.23% w/v. Thus, the 
novel formulation of chitosan-MT gives newer prolongation of action.
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